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Abstract
Background: Autosomal dominant familial cortical myoclonic tremor and epilepsy (FCMTE) is characterized by distal tremulous myoclonus, generalized seizures,
and signs of cortical reflex myoclonus. FCMTE has been described in over 100 pedigrees worldwide, under several different names and acronyms. Pathological
changes have been located in the cerebellum. This systematic review discusses the clinical spectrum, treatment, pathophysiology, and genetic findings.
Methods: We carried out a PubMed search, using a combination of the following search terms: cortical tremor, myoclonus, epilepsy, benign course, adult onset,
familial, and autosomal dominant; this resulted in a total of 77 studies (761 patients; 126 pedigrees) fulfilling the inclusion and exclusion criteria.
Results: Phenotypic differences across pedigrees exist, possibly related to underlying genetic differences. A ‘‘benign’’ phenotype has been described in several
Japanese families and pedigrees linked to 8q (FCMTE1). French patients (5p linkage; FCMTE3) exhibit more severe progression, and in Japanese/Chinese
pedigrees (with unknown linkage) anticipation has been suggested. Preferred treatment is with valproate (mind teratogenicity), levetiracetam, and/or clonazepam.
Several genes have been identified, which differ in potential pathogenicity.
Discussion: Based on the core features (above), the syndrome can be considered a distinct clinical entity. Clinical features may also include proximal myoclonus
and mild progression with aging. Valproate or levetiracetam, with or without clonazepam, reduces symptoms. FCMTE is a heterogeneous disorder, and likely to
include a variety of different conditions with mutations of different genes. Distinct phenotypic traits might reflect different genetic mutations. Genes involved in
Purkinje cell outgrowth or those encoding for ion channels or neurotransmitters seem good candidate genes.
Keywords: Familial, cortical, myoclonus, tremor, epilepsy, genetics
Citation: van den Ende T, Sharifi S, van der Salm SMA, van Rootselaar AF. Familial cortical myoclonic tremor and epilepsy, an enigmatic disorder: from
phenotypes to pathophysiology and genetics. A systematic review. Tremor Other Hyperkinet Mov. 2018; 8. doi: 10.7916/D85155WJ
* To whom correspondence should be addressed. E-mail: a.f.vanrootselaar@amc.uva.nl
Editor: Elan D. Louis, Yale University, USA
Received: August 11, 2017 Accepted: January 2, 2018 Published: January 23, 2018
Copyright: ’ 2018 van den Ende et al. This is an open-access article distributed under the terms of the Creative Commons Attribution–Noncommercial–No Derivatives License, which




Conflicts of Interest: The authors report no conflicts of interest.
Ethics Statement: Not applicable for this category of article.
Introduction
Autosomal dominant familial cortical myoclonic tremor and epilepsy
(FCMTE) has over the years accumulated several names and acronyms
including autosomal dominant cortical myoclonus and epilepsy (ADCME),
benign adult familial myoclonic epilepsy (BAFME), cortical tremor (Crt Tr),
familial adult myoclonic epilepsy (FAME), familial cortical myoclonic
tremor (FCMT), familial cortical tremor with epilepsy (FCTE), familial
essential myoclonus and epilepsy (FEME), familial benign myoclonus
epilepsy of adult onset (FMEA), and heredofamilial tremor and epilepsy
(HTE) (Table 1).1 FCMTE will in the manuscript serve as the acronym for
all abbreviations, as suggested in 2005,2 and as currently classified by the
HUGO Gene Nomenclature Committee (HGNC).3 The syndrome was
first described in the 1990s in Japan, in families with hereditary tremor
(distal tremulous myoclonus) and epilepsy.4–7 Subsequently, over a hundred
pedigrees have been identified in different countries, which have proven to
be genetically heterogenic in linkage studies.
Symptoms of FCMTE are tremor-like cortical myoclonus, which
can mimic essential tremor (ET), and epileptic seizures. Distal tremulous
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movements are usually the first symptom, usually with an onset in the
second or third decade. Seizures, most often unprovoked generalized
tonic–clonic seizures without aura, start later in life, frequently in the
third or fourth decade. Diagnosis is based on clinical characteristics
and family history, and is supported by electrophysiological investiga-
tions, after exclusion of other tremulous disorders and epileptic syn-
dromes. Treatment is symptomatic, usually with anti-epileptic drugs
such as valproate and clonazepam.
Additional symptoms have also been described, possibly extending
the spectrum of the disease. These include mild cognitive decline8–12
but also psychiatric symptoms,13 nystagmus,14 and migraine.15–18 Clinical
anticipation has been described in Asian pedigrees.19–21 It is unknown
which of these symptoms are part of FCMTE or are co-incidental,
and which symptoms might differentiate between underlying genetic
mutations.
FCMTE maps to different loci including 8q23.3-q24.13 (Online
Mendelian Inheritance in Man [OMIM],22 HGNC,23 FCMTE1) in
Japanese families24–26 and a Chinese pedigree;27 2p11.1-q12.2 (OMIM,28
HGNC,23 FCMTE2) in multiple Italian pedigrees,8,9,17,29–33 a Spanish
family,29,34 and a family from New Zealand/Australia with ancestors
from Austria;16 5p15.31-p15 (OMIM,35 HGNC,23 FCMTE3) in a
French family,29,36–38 a Dutch pedigree,39 and two Chinese pedi-
grees;40,41 and 3q26.32-3q28 (OMIM,42 FCMTE4) in a Thai family.43
Also, an autosomal recessive form of FCMTE (OMIM,44 FCMTE5)
has been identified in an Egyptian family where a mutation has been
localized in the contactin 2 (CNTN2) gene, which is associated with
potassium channel stability.45 In autosomal dominant FCMTE,
several possible gene mutations have been proposed as causative on
the FCMTE loci.27,46–49 Recently, a mutation was found in a Dutch
FCMTE3 pedigree in the catenin delta 2 (CTNND2) gene, supported
by functional tests.39
Neurophysiological, imaging, genetic, and pathology findings
have shed some light on the pathophysiology underlying FCMTE.
A cortical origin of the myoclonus in FCMTE is proven by electro-
physiological investigation consistent with reduced cortical inhibi-
tion.14 Pathology findings in a Dutch FCMTE pedigree indicate
Purkinje cell changes, resembling the abnormal neuronal morphology
in Ctnnd2 mutant mice.1,39,50 Congruent imaging findings include
decreased fiber density,51 functional connectivity alterations52 and
gray matter loss in the cerebellar motor area.53 It has been hypo-
thesized that, via the cerebello-thalamo-cortical loop, reduced input
from the cerebellum can lead to cortical hyperexcitability.54 However,
the question arises if the cerebellum is the primary generator of cortical
hyperexcitability in all FCMTE types. Alternatively, cortical func-
tional changes could underlie the symptoms, with or without coexisting
cerebellar pathology.
This review will bring together evidence concerning the clinical
spectrum including treatment on the one hand, and, on the other
hand, pathophysiological and genetic studies, adding the latest insights.1
The current review aims to not only summarize studies into FCMTE,
but also be of guidance to the clinician encountering a patient with
suspected FCMTE. A second aim is to link insights from pathophy-
siological studies to genetic studies to better understand the underlying
disease mechanisms and be a guide for future research and better
treatment of these patients.
Methods
We conducted a PubMed search on November 15, 2017, for the
period January 1, 2011, to November 15, 2017, using a combination
of the following search terms: cortical tremor, myoclonus, epilepsy,
benign course, adult onset, familial, autosomal dominant, and the
different acronyms for FCMTE fully written; see Appendix A for
complete search terms. The search delivered a total of 1,180 articles,
and one additional from reference lists, from which 33 fulfilled the
selection criteria (flow chart, Figure 1). The search conducted for our
previous review in 2011 had already revealed a total of 44 publications
published before 2011,1 which are also included in the current review
(Tables 2 and 3).
Included were reports published in English describing pedigrees
with the following diagnostic criteria as previously reported:1
1) distal action and postural tremor/fine myoclonus; 2) generalized
tonic–clonic seizures and/or electrophysiological features of
cortical reflex myoclonus including giant somatosensory evoked
potentials (SEPs) and/or enhanced long loop reflexes (LLRs/C
reflex); and 3) a family history of tremor/epilepsy consistent with
autosomal dominant inheritance. Excluded were pedigrees and
cases with another cause for tremor and epilepsy (including
autosomal recessive FCMTE45), structural lesions on magnetic
resonance imaging (MRI), and additional symptoms such as clear
parkinsonism, dementia, and/or ataxia pointing to a different
syndrome.
Table 1. Familial Cortical Tremor/Myoclonus Syndromes
Acronym
ADCME Autosomal dominant cortical myoclonus and
epilepsy
BAFME Benign adult familial myoclonic epilepsy
Crt Tr Cortical tremor
FAME Familial adult myoclonic epilepsy
FCMT Familial cortical myoclonic tremor
FCMTE Familial cortical myoclonic tremor with epilepsy
FCTE Familial cortical tremor with epilepsy
FEME Familial essential myoclonus and epilepsy
FMEA Familial benign myoclonus epilepsy of adult onset
HTE Heredofamilial tremor and epilepsy
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Results
In total 77 publications (126 pedigrees; 761 patients) were retrieved
from the combined current PubMed search and the 2011 search.1 For
an overview of additional pedigrees since our last review1 see Table 2.
Table 3 shows the pedigrees previously identified.1 Since 2011,
70 additional pedigrees in 33 publications, including 48 from India,
have been extensively described (providing clinical and electrophysio-
logical data, Table 2).16–18,21,27,40,41,43,46–48,55–59 Descriptions of the
pedigrees comply with autosomal dominant inheritance. The reports
used uniform criteria for diagnosing FCMTE, and one paper explicitly
stated they used the diagnostic criteria from our last review.55 The
reports vary in detail in their description of the neurological exami-
nation, the presence or absence of cerebellar signs, of cognitive assess-
ment, comorbid psychiatric disorders, effect of anti-epileptic drugs on
tremor/epileptic seizures, drug dosage, clinical anticipation, structural
imaging, and electrophysiological investigation including jerk-locked
back averaging (JLA). Owing to insufficient clinical/electrophysiological
data, several new families were not included in Table 2.13,19,20,29,60
Figure 1. Article Selection Flowchart. Literature search for the identification of new pedigrees, genetic/linkage or imaging studies since our last review.1
Thirty-three articles were eligible for analysis: 17 reported on clinical and electrophysiology findings with or without linkage analysis, nine reported on
neuroimaging, and seven reported on new potential pathogenic mutations. Abbreviations: DAT-SPECT, Dopamine Transporter, Single Photon Emission
Computed Tomography; DTI, Diffusion Tensor Imaging; FCMTE, Familial Cortical Myoclonus Tremor And Epilepsy; fMRI, Functional Magnetic
Resonance Imaging; 1H-MRS, Proton Magnetic Resonance Spectroscopy; VBM, Voxel Based Morphometry.
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The results section covers both the previously identified and novel
pedigrees.
The FCMTE phenotype; core characteristics and less common
findings
Clinical spectrum. FCMTE usually starts with tremor-like, cortical
myoclonus of the distal limbs, with onset in the second or third decade
(range 3–70 years). Epileptic seizures usually start in the third or fourth
decade (range 5–76 years), for which patients often seek medical atten-
tion. However, epileptic seizures can also be the first symptom.17,21,43,56
The tremulous movements are in fact small, high-frequency myo-
clonic jerks, induced by posture or action. They can be mild, but can
also be more incapacitating.17,27,47,57,58 When present in the lower
limbs, these may lead to gait disorders17,36–38,58,61 and even ‘‘drop
attacks’’.16,18 These tremor-like movements during action can easily
be mistaken for ET. Electrophysiological measures can distinguish
FCMTE from ET, showing short irregular electromyography (EMG)
bursts during action and a cortical drive. Stimulus-sensitive myoclonus,
frequently present in FCMTE, may be triggered or worsened by
alcohol, emotional stress, sleep deprivation, tactile stimuli, and photic/
phonic stimulation.16,17,21,37,47,56,57,62 Twitching movements can
involve facial/axial muscles.16,21,57,58 Alcohol responsiveness has been
reported in two pedigrees.16,58 Myoclonus may remain stable, but
long-term follow-up is not always present.18,40,41 Also, myoclonus has
been reported to worsen with progressing age.10,16,17,21,36,57,58,63
Epileptic seizures are usually generalized tonic–clonic seizures, but
can also be complex partial seizures.8,37,46,56 Recently the latter were
renamed as focal seizures with impaired awareness (International
League Against Epilepsy [ILAE] 2017 classification).64 Moreover, they
can be drug resistant.46 Focal seizures with mesiotemporal symptoms
or motor symptoms (de´ja` vu and fear) have been reported in four
patients.16,46 Generalized seizures mostly start without a warning sign
but sometimes are preceded by severe myoclonus.16,56 Also, myoclonic
seizures have been described.11,17,18 Seizures are reported to be induced
by sleep deprivation, photic stimulation, stress, excitement,16,37,47,62 or
snow.21 Frequency is usually low. Over five seizures per year is
uncommon,13,16,17,21,27,43,47,58 but more severe cases (>10 seizures per
year) have been described.10,18,37
Additional clinical findings, possibly extending the clinical spectrum,
are listed below.
- Cerebellar findings include in French pedigrees mild ataxia and
gait instability,17,37,38,62 (downbeat) nystagmus increasing with hyper-
ventilation in a Dutch pedigree,14 and dysarthria in South African/
French pedigrees.10,38 Ataxia is not a feature of FCMTE16,17,27,47,57,58,60,65
but subtle cerebellar signs have not explicitly been ruled out.
- Mild cognitive decline, not including dementia, has been noted in
some papers.8–12,52,57
- Psychiatric comorbidity has been noted in seven Italian families
(FCMTE2),13,17 anxiety in Indian patients,56 schizophrenia in a
Chinese pedigree,66 and psychiatric comorbidity in a Turkish
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personality disturbances (hypochondriasis and schizophrenia)
were more prevalent in Italian FCMTE pedigrees than juvenile
myoclonic epilepsy and healthy controls.13
- Clinical anticipation has been recognized in Japanese patients with
unknown linkage: tremor started at a younger age and seizures
newly appeared in the next generation.19,20 Possibly, maternal
transmission is associated with this phenomenon.20 In Chinese
patients paternal transmission was noted in the earlier onset of
tremor but not of seizures.21
- Other findings include migraine,15–18 ophthalmic migraine,37
headaches,40 logopenic syndrome,67 visual intolerance,61 frontal
dysfunction,61 night blindness,68 motionless state,69 absence
seizures,18 parkinsonism,48 reduced verbal fluency,70 sensitivity to
glucose deprivation or vibration as an aggravating factor,37,38 and
visuospatial impairment.9,52
Electrophysiological findings. Additional investigations in patients sus-
pected of FCMTE to aid the diagnosis include electroencephalography
(EEG), EMG, SEP, LLR, JLA, and corticomuscular (EEG-EMG)
coherence analysis.
EEG findings may include generalized (poly) spikes and waves,
photoparoxysmal response, and photomyogenic responses (Tables 2
and 3). EMG shows arrhythmic/semi-rhythmic high-frequency (>10 per
second) burst-like discharges of about 50 ms, which can be synchro-
nous between agonist and antagonist muscles, typical for cortical
myoclonus.71
Often features of cortical reflex myoclonus are present, including
giant SEP, enhanced LLR, and/or cortical spikes preceding myoclonus
with JLA.71 EEG-EMG coherence analysis indicated strong cortico-
muscular coherences around 20 Hz with a cortical drive.72 With aging
giant SEP and JLA cortical spike amplitude can be enhanced in
FCMTE patients.16,73 Not all patients have giant SEPs or LLR,
possibly due to anti-epileptic drug (AED) use,33 although giant SEP
amplitude can also increase with AED use.21
Imaging. Structural imaging with MRI is normal in most cases.
Although slight cerebellar atrophy (e.g., vermis)10 has been described.9–11,48
In one patient corticospinal degeneration was present.48 In three patients
basal ganglia/periventricular white matter changes were observed.10
Treatment. The treatment of FCMTE consists of the prevention of
epileptic seizures and/or reduction of troublesome tremor/myoclonus
mainly with AEDs and benzodiazepines. Valproate is the drug most often
reported to be effective with or without clonazepam.13,16,17,27,43,47,48,56,58,60,65,74
Because of teratogenicity, this should not be prescribed to women
of childbearing age. Newer AEDs with a good effect are leveti-
racetam13,17,37,38,43,46,48,58,74,75 and lamotrigine.37,58 Other drugs pre-
scribed to prevent seizures in FCMTE are phenobarbital, phenytoin,
carbamazepine, clobazam, oxcarbazepine, and primidone.1,16,40,43,47,48,58,60,74
One report observed a reduction in tremulous movements from a
b-blocker.16 One to three AEDs usually prevents seizures or reduces
them to once a year. Gabapentin has been reported to precipitate
myoclonic status.76
Pathophysiology
Cortical hyperexcitability can be considered the hallmark of FCMTE.
However, cerebellar changes have been described in neuroimaging
and pathology studies.
Cortical hyperexcitability. Electrophysiological findings in FCMTE
point to cortical hyperactivity and a cortical origin of the tremulous
myoclonic movements. Functional (f)MRI-EMG also indicated cortical
activity linked to the tremulous movements.77 Transcranial magnetic
stimulation (TMS) in European pedigrees revealed a reduction in short
interval cortical inhibition compared with healthy controls, reflecting
hyperexcitability of the cortex.9,14 In Japanese FCMTE patients the
giant SEP was enhanced, lacking the long-term depression effect seen
in healthy controls after quadripulse TMS over the primary motor
cortex.78 However, post-mortem pathology studies in three Dutch
cases revealed limited involvement of the sensorimotor cortex.1,14,50
Cerebellar involvement. Evidence for cerebellar involvement differs
between FCMTE types (Table 4, imaging overview). For FCMTE1
and 4 there are no imaging or pathology studies available. In FCMTE2
a proton magnetic resonance spectroscopy (MRS) study indicated
cerebellar dysfunction.79
In the Dutch FCMTE3 pedigree, with a CTNND2 gene mutation39
several findings point to cerebellar changes. These include, in certain
family members, a downbeat nystagmus upon hyperventilation14 and
in three deceased cases there was Purkinje cell loss in the cerebellar
cortex and abnormal morphology of Purkinje cells during pathological
examination.1,14,50
In family members of these deceased Dutch patients a mutation was
found in the CTNND2 gene that led to abnormal neuronal sprouting in
mice neurons, resembling the aforementioned cerebellar pathology.39
Moreover, imaging findings in the same pedigree showed decreased
cerebellar fiber density51 and gray matter loss in the cerebellar
motor area.53 In a Chinese pedigree in which 8q and 2p linkage
was excluded, MRS indicated cerebellar dysfunction65 and a fMRI
study indicated alterations between the cerebellum and supratentorial
structures after network analysis.52 A South African pathology case,
from a pedigree in which 8q and 2p linkage was excluded, revealed
focal Purkinje cell loss, neuronal atrophy in the dentate nucleus, and
neuronal loss with gliosis in the olives and pallidum.10
Other findings. A functional MRI/voxel-based morphometry (VBM)
study indicated gray matter loss in cortical and subcortical structures
with connectivity alterations.70 In a resting state fMRI study, com-
pared to ET and healthy controls, the right fusiform gyrus and the
posterior cingulate cortex showed decreased amplitude of low-frequency
fluctuation (ALFF), and the frontal lobe showed increased ALFF that
correlated with disease duration.55 In two FCMTE patients with gait
difficulties but no benefit from L-dopa in one, MRI showed frontal
atrophy and single positron emission computed tomography (SPECT)
showed dopamine depletion.61 In a FCMTE patient with a language
disorder and short-term memory problems, MRI showed frontal
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atrophy and SPECT indicated loss of dopamine transporters in the left
striatum.67
Genetic linkage, proposed mutations
In several FCMTE pedigrees, causative mutations have been
proposed (Table 5). In a Dutch pedigree a mutation in CTNND2,
supported by functional tests, has recently been discovered.39 How-
ever, functional tests have not been performed for every mutation.80
Linkage studies indicated several loci: 8q23.3-8q24.13 (FCMTE1)24–27;
2p11.1-q12.2 (FCMTE2)8,9,16,17,29–34; 5p15.31-p15 (FCMTE3)29,36–41;
and 3q26.32-3q28 (FCMTE4).43 Furthermore, there are several families
(Chinese, Spanish, Italian, South African) in which 2p and/or 8q linkage
was excluded.10,62,66,81 Below we summarize the findings in FCMTE1–4
and FCMTE-like disorders.
Linkage to the FCMTE1 locus on chromosome 8q23.3-8q24.13 was
found in several Japanese families24–26 and one Chinese family.27 In
the Chinese pedigree a single nucleotide variant (SNV) was identified
in the SLC30A8 (solute carrier family 30 [zinc transporter]) gene after
whole-exome sequencing (WES).27 However, there is no expression of
this gene in the brain, making it irrelevant.27 Besides, sequence and
copy number variant analysis of the genes located on the 8q23.3-
8q24.13 locus did not reveal any mutation.26
Linkage to the FCMTE2 locus on chromosome 2p11.1-q12.2 was
found in Italian,8,9,17,29–33 Spanish,29,34 and Australian/New Zealand
pedigrees (with European ancestors).16 A founder haplotype was
identified in Italian FCMTE2 pedigrees from the same geographical
area.17,29 A mutation in two Italian family members within the
FCMTE2 locus was found on the a2-adrenergic receptor subtype B
(ADRA2B) gene with next-generation sequencing (NGS).46 Identity by
descent mapping (IBD), which is able to detect genetic loci with an
ancestral segment among pedigree unrelated individuals, refined the
FCMTE2 locus to 2p11.1-q11.1 without excluding the ADRA2B
mutation.29 In a Spanish pedigree, WES indicated an SNV in the
aminocarboxymuconate semialdehyde decarboxylase (ACMSD) gene
encoding for an enzyme that is part of the kynurenine pathway
of tryptophan and linked to neurodegenerative diseases and
epilepsy.48
FCMTE3, with linkage to 5p15.31-p15, has been identified in two
Chinese families,40,41 a Dutch pedigree,39 and a French family.29,36–38
In the Dutch family after WES, a mutation was found in the CTNND2
gene.39 Knockdown of Ctnnd2 in cortical mouse neurons led to
abnormal neuronal sprouting which resembled abnormal Purkinje cell
morphology in deceased FCMTE patients.39 However, in the French
family a mutation in SEMA5A (semaphorin-5A) and CTNND2 genes
was excluded using direct sequencing.36 Carr et al.10 have named their
South African pedigree FAME3; however, only analysis to exclude the
linkage areas 2p and 8q was performed.
FCMTE4, with linkage to 3q26.32-3q28, has recently been dis-
covered in a Thai family.43 No causative gene has yet been identified.
Two candidate genes have been proposed for FCMTE4: HTR3D
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potassium channel subunit beta-3), which encode for ion channel
receptors.29
Other proposed mutations include a missense mutation on 8q22.3 in
ubiquitin protein ligase E3 component n-recognin 5 (UBR5) within a
Japanese pedigree, linked to Angelman syndrome and autosomal
recessive juvenile parkinsonism.59 In a Chinese family, a missense
mutation at 22q13.1 in PLA2G6 (phospholipase A2 Group VI) was
found using WES.47 Pathogenicity is hypothetical. PLA2G6 mutations
have also been linked to infantile neuroaxonal dystrophy and the
enzyme encoded by PLA2G6 is involved in the synthesis of arachidonic
acid; abnormal metabolism of arachidonic acid could lead to neuronal
hyperexcitability.47
Genetic findings in FCMTE-like disorders. In a family from Canada
with familial cortical myoclonus without seizures (a potential new
disorder), linkage analysis and WES identified a missense mutation on
16q22.1 in the nucleolar protein 3 (NOL3) gene.49 Pathogenicity is
doubtful because Nol3 knockout mice did not exhibit myoclonic
symptoms and had normal SEPs.49 Moreover there is an autosomal
recessive form of FCMTE, caused by a single base pair deletion in
CNTN2, crucial for the stability of potassium channels.45
Discussion
In this systematic review we included a total of 126 FCMTE
pedigrees (761 patients), including 70 additional FCMTE pedigrees
(275 patients) since our 2012 review.1 Here we discuss the diagnostic
criteria, clinical spectrum, and treatment. Also, we suggest features
that might relate a phenotype to a specific genotype, and focus on the
pathophysiology combining neurophysiological, imaging, and patho-
logy studies, as well as on potential candidate genes.
Diagnostic criteria and clinical spectrum
The pedigrees presented in this review share the core features of
FCMTE, including autosomal dominant inheritance, distal myoclonic
tremor with signs of cortical reflex myoclonus, and/or generalized
tonic–clonic seizures. Myoclonus is typically the first symptom, while
seizures, usually occurring later in the disease course, are a common
reason for patients to seek medical care. However, seizures might in a
number of cases be the first symptom.56
EEG findings in FCMTE include generalized spikes/waves and
photoparoyxsmal or photomyogenic responses. Other possible clinical
features include mild progression of symptoms with aging,16,17,21,57–59
and proximal myoclonus, potentially leading to gait disorders, across
linkage types or European/Asian descent.16,17,37,46,56–58,61,65,67 Both
are not major inclusion criteria but phenomena that are frequently
observed and seem to be part of the disease spectrum.
Focal EEG abnormalities and a slower posterior dominant rhythm
might be features of FCMTE.56,74 Also, EEG may show generalized
spikes and waves preceding later onset of epilepsy.58
FCMTE is differentiated from other tremor-like disorders (including
ET) with electrophysiological recordings.32 FCMTE can be differ-
entiated from the progressive myoclonus epilepsy syndromes and
juvenile myoclonic epilepsy (JME) in the absence of severe cognitive
decline and absence of severe ataxia.82 Unlike FCMTE, JME presents
with myoclonus in the morning and shows no features of cortical reflex
myoclonus.82
Criteria for the diagnosis of FCMTE are the following:
1) Distal action and postural tremor/fine myoclonus, accompanied
by generalized tonic-clonic seizures in at least one family member.
Also, mild progression of symptoms with aging and proximal
muscle myoclonus can be present.
2) Electrophysiological measures support the diagnosis: giant SEP
and LLR point to cortical hyperexcitability; polymyography
showing discharges of ,50 ms suggest cortical myoclonus; and
EEG-EMG coherence analysis or JLA can support a cortical
origin of the tremulous movements.
3) Autosomal dominant inheritance of epilepsy and ‘‘tremor’’/
myoclonus within the family.
4) No other cause for tremor, epilepsy. No other symptoms must be
present like ataxia, parkinsonism, dementia, dystonia, spasticity.
Are phenotypical differences related to specific mutations?
Differences in symptomatology have been reported, possibly linked
to different mutations.1 Japanese and Chinese pedigrees, linked to 8q
(FCMTE1; also known as BAFME) suffer from a more ‘‘benign’’ form
of FCMTE with age of onset in the third decade, infrequent seizures,
and no cognitive decline.24,25,27 Usually, FCMTE1 patients present
with rhythmic distal myoclonus of the upper extremities, but more
extensive involvement of the lower extremities and facial muscles has
also been reported.24,68,83
Pedigrees with linkage to 2p (FCMTE2) exhibit a more severe
form of myoclonus (proximal involvement) that progresses with aging
and leads to gait disability.16,17,46 Specific for Italian 2p pedigrees,
psychiatric comorbidity is frequently present.13 Atypical symptoms in
pedigrees with a possibly pathogenic mutation were present in Spanish
2p ACMSD patients (n:1 parkinsonism and mild ataxia)48 and in 2p
ADRA2B patients (focal seizures and age-related dementia).46
Linkage to 5p (FCMTE3) in two Chinese pedigrees is related to
a benign course with age of onset in the fourth decade, and, during
short-term follow-up, no disease progression.40,41 However, in French
FCMTE3 pedigrees, progression of symptoms, gait disability, frontal
syndrome, cognitive changes, and logopenic syndrome were described.61,67
Also, in a Dutch FCMTE3 pedigree subjective cognitive decline was
present.39
In a Thai pedigree, with linkage to 3q (FCMTE4), myoclonus pre-
sented earlier, in the second decade, and seizures started in the third
decade.43 No cognitive decline was present.43
In patients with unknown linkage the following findings were reported:
clinical anticipation was present in Asian pedigrees (measured with
rating scales).19–21 Mild cognitive decline was present in Asian
patients.21,57 European patients (or with European ancestors) suffered
from mild cognitive decline,8–12,17,39,47,48 focal seizures,16,46 mild
ataxia and/or gait instability,16,17,37,38,48 nystagmus,14 dysarthria,10,38
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and migraine.15–18 Atypical features were also described in a Turkish
family, including absence seizures, early onset of seizures (14–17 years),
negative LLR (while using AEDs), and frequent myoclonic seizures
(once a month).18
There are a number of possible explanations for the reported
phenotypical differences between pedigrees/FCMTE types. Firstly,
different mutations, extensively described in a limited number
of pedigrees, could lead to clinical diversity.39,46–48,59 For instance,
more severe disease course,17,36 cognitive decline,67 and/or the
pathological/neuroimaging changes in the cerebellum1,51,53 might be
related to specific FCMTE mutations. Secondly, the clinical dif-
ferences could be co-incidental or based on comorbidity, either related
or unrelated to FCMTE. Other possible explanations might be
differences in genetic trait other than FCMTE; heterogenic prescrip-
tion regimes, including AED use per country, or environmental factors.
A third explanation is reporting bias. Documentation, investigations, and
follow-up differ substantially between pedigrees.
Pathophysiology
The primary symptoms of FCMTE, cortical myoclonus, and epilepsy
seem to have their origin in the sensorimotor cortex. Electrophysiology
findings indicate cortical hyperexcitability with generalized spikes and
waves on EEG, giant SEP, LLR, and reduced cortical inhibition in
TMS studies9,14,78 and cortical activity preceding the onset of move-
ment (EEG-EMG back averaging and coherence analysis), confirmed
with combined EMG/fMRI.72,77,84
Cerebellar changes might be a key feature of FCMTE. Pathology
findings in three Dutch patients1,14,50 and one South African patient10
report severe loss of Purkinje cells with dendritic sprouts, neuronal loss
in the dentate nucleus and microglia activation with limited changes in
the sensorimotor cortex. Use of AEDs might result in loss of Purkinje
cells. Notwithstanding, cerebellar pathology findings in FCMTE
patients differ from changes seen in patients with chronic idiopathic
epilepsy who used phenytoin85 and rats chronically exposed to valproic
acid.86 Also, Dutch patients who did not use AEDs had a downbeat
nystagmus upon hyperventilation, indicating cerebellar dysfunction.14
Moreover, a mutation in CTNND2 was found in the same Dutch
pedigree, probably related to FCMTE3, as the gene CTNND2 is
located on the same linkage area.39 A mutant version of this gene was
responsible for abnormal neuronal sprouting in mouse neurons,
resembling cerebellar pathology findings in the same Dutch pedi-
gree.39 In a French FCMTE3 pedigree a mutation in CTNND2 was
excluded using direct sequencing.37 It could be there are several
mutations located on the same linkage area or the mutation was
undetectable due to the technique used.
Pathological cerebellar involvement is in line with cerebellar signs in
European FCMTE pedigrees; these include downbeat nystagmus,14
mild ataxia (although possibly difficult to judge in the presence of
tremulous myoclonus),37,38 dysarthria,10,38 and imaging findings
revealing cerebellar involvement.51,53,79
Further evidence for cerebellar involvement in FCMTE arises from
imaging studies in FCMTE, indicating functional connectivity changes
between the cerebellum and cortical/subcortical structures.52 Supra-
tentorial gray matter loss outside the motor circuit might be secondary.70
Also, cerebellar atrophy and ataxia have frequently been noted in
patients with epilepsy.87 Repetitive TMS over the cerebellar cortex
was able to reduce seizure frequency in drug-resistant epilepsy.87,88
The cerebellum might be involved in psychiatric disorders.89 In several
FCMTE pedigrees anxiety and depressive comorbidity was reported.13,56
With aging, Purkinje cells become atrophic in healthy adults and
the amount of white matter is reduced in the cerebellum.90 The
degeneration of Purkinje cells might be enhanced in FCMTE patients
leading to defective compensatory input to cortical structures. Clini-
cally, this could explain the later onset of seizures and the worsening of
symptoms with aging.16 Moreover, cortical hyperexcitability seems to
increase with aging in Japanese patients, reflected by higher giant SEP
amplitude.73
Pathology, imaging, genetic, and clinical findings indicate cerebellar
changes. This offers a possible explanation for the decreased cortical
inhibition. Deficient stimulation of the dentate nucleus by Purkinje
cells in the cerebellum may lead to increased cortical facilitation via the
cerebello-thalamo-cortical loop, a hypothesis already raised for cortical
myoclonus and epilepsy.54,87,91 Purkinje cell changes might however
not be the (sole) explanation for the symptoms observed in FCMTE.
The cerebellar changes might be specific for certain FCMTE types,
with the strongest evidence for FCMTE3. Future research is needed to
indicate whether cerebellar involvement, including pathological cere-
bellar changes, is a general finding in FCMTE. In some FCMTE types
it might be co-existent, secondary due to primary cortical pathology,
or even absent.
Possible candidate genes
Possible candidate causative genes include a trinucleotide repeat
expansion or channelopathy.80 Purkinje cell changes in deceased
Dutch FCMTE patients show striking similarities with those found
in spinocerebellar ataxia (SCA) type 6, characterized by ataxia and
downbeat nystagmus.1,50 Patients from the same Dutch FCMTE
pedigree also have a downbeat nystagmus.14 SCA type 6 is caused by a
CAG repeat in a calcium channel CACNA1A heavily expressed in
the cerebellum.92 Other observations that might also point to a
trinucleotide repeat expansion or channelopathy underlying FCMTE
include in Asian FCMTE pedigrees, progressively earlier onset of the
disease with increasing severity in successive generations19–21; presence
of migraine15–18 analogues to hemiplegic migraine with mutations
in calcium channels93; and the recognition that certain epilepsy
syndromes are channelopathies.45,94 Recently, an autosomal recessive
form of FCMTE has been recognized with a single base pair deletion
in CNTN2, crucial for the stability of potassium channels.45 A chan-
nelopathy could involve cerebellar cells and/or induce functional
cortical changes.50,92
Several genes have been identified as potentially causative in
FCMTE. A gain of function mutation in the ADRA2B gene has been
found in Italian FCMTE2 pedigrees that could potentially alter the
neuronal firing pattern and even reduce gamma-aminobutyric acid
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(GABA) neurotransmission.46 A reduction in cortical GABA neuro-
transmission has been associated with cortical myoclonus in rats,
progressive myoclonus epilepsy and Unverricht–Lundborg disease
characterized by cortical myoclonus and ataxia along with seizures.91
Treatment with AEDs increasing GABA neurotransmitter levels can
relieve the symptoms of FCMTE.
Another neurotransmitter implied in the pathophysiology of
FCMTE2 is serotonin.48 A mutation in the ACMSD gene, encoding
for an enzyme that is part of the kynurenine pathway, might lead
to the accumulation of waste products.48 In mice, seizures could be
induced when injecting these kynurenines in the brain ventricles.95
In Dutch FCMTE3 patients, a mutation in CTNND2, supported by
functional tests in mice, seems to be responsible for abnormal neuronal
sprouting.39 Hypothetically, the pathology findings in the cerebellum
and the disease itself are caused by the CTNND2 mutation.39
Other proposed mutations/linkage studies have not yet elucidated
the pathophysiology of FCMTE and have provided conflicting results,
including proposed mutations outside the known linkage areas (UBR5,
PLA2G6)47,59 and a pedigree from Canada (NOL3 mutation)49 without
seizures, possibly reflecting another illness. The lack of progress might
be due to the inability of next-generation sequencing techniques to
detect exon rearrangements, trinucleotide repeat expansion, and copy
number variants.80 Even a deletion in an intron might lead to defective
splicing of a gene as in Unverricht–Lundborg disease.96 New algo-
rithms and WGS might lead to a breakthrough.97,98
Future genetic studies should focus on mutations in proteins
expressed in the cerebellum, involved in neuronal outgrowth, calcium,
sodium, or potassium signaling, GABA neurotransmission, and genes
which interact with the SCAs or other diseases with cortical myoclonic
symptoms.80
Limitations
Reporting bias may have influenced our results. The number of
patients and follow-up differ between pedigrees. Across studies, rating
scales for motor symptoms and cognitive functioning differ or have not
been reported. Therefore, symptoms might have been underreported,
for instance cerebellar dysfunction and cognitive deterioration in
certain pedigrees.14 Additional investigations (MRI, electrophysiology,
pathology) have not always been performed, in some cases leading to
diagnostic uncertainty, but more often raising questions with respect to
generalizability of findings across pedigrees. For instance, both the
imaging and the pathology findings involving cerebellar changes have
largely been confined to a South African patient (linkage exclusion 2p, 8q),
a Dutch pedigree (FCMTE3), and Chinese patients (linkage exclusion 2p, 8q)
making the generalizability of the findings problematic.10,39,51–53,65,70
Several mutations (ACMSD, ADRA2B, UBR5, PLA2G6) have been
proposed but pathogenicity has still to be proven.46–48,59
Conclusion
FCMTE, also known under different names and acronyms, is
a clinical entity not (yet) listed by the ILAE. It is characterized by
cortical tremor/fine myoclonus and generalized tonic–clonic seizures
with autosomal dominant inheritance. Proximal myoclonus and mild
progression with aging are part of the spectrum. Electrophysiology
recordings show features of cortical reflex myoclonus. Valproate (not
recommended in women of childbearing age) or levetiracetam, with or
without clonazepam reduce symptoms. Gabapentin should be
prescribed cautiously.
FCMTE is a heterogeneous disorder, and is likely to include a
variety of different conditions with mutations of different genes.
Additional symptoms have frequently been reported and can be
co-incidental or based on genetic differences. Pathophysiological
mechanisms remain to be elucidated, but pathology, genetic, and
imaging studies have given clues that indicate cerebellar involvement.
The cerebellar changes might lead to reduced cortical inhibition.
Alternatively, underlying genetic changes induce both cerebellar and
cortical changes. Genetic heterogeneity is present in linkage studies.
Several causative genes have been suggested. However, functional tests
have not always been performed.
Pathophysiology and genetic studies indicate that future genetic
studies should focus on mutations involving Purkinje cell outgrowth,
channelopathies, or genes responsible for neurotransmitter synthesis.
Appendix A
PubMed search
Conducted on 15-11-2017, articles were sought from 01-01-2011 to
15-11-2017.
((((cortical tremor myoclonus) OR cortical tremor epilepsy) OR
(((((‘‘Tremor’’[Mesh]) AND ‘‘Myoclonus’’[Mesh]) AND ‘‘Epilepsy’’
[Mesh])) OR ((cortical tremor [tiab] AND epilepsy [tiab] AND
myoclonus [tiab])))) OR (((((((((((‘‘Epilepsy, Myoclonic, Benign Adult
Familial, Type 1’’[Supplementary Concept]) OR (‘‘Tremor’’[Mesh]
AND ‘‘Epilepsy’’[Mesh])) OR (‘‘Tremor’’[Mesh]) AND ‘‘Myoclonus’’
[Mesh])) OR (‘‘Epilepsy’’[Mesh] AND ‘‘Myoclonus’’[Mesh])) OR
(autosomal dominant [tiab] AND ‘‘Epilepsy’’[Mesh]) AND ‘‘Myoclonus’’
[Mesh])) OR (autosomal dominant [tiab] AND ‘‘Tremor’’[Mesh]
AND ‘‘Myoclonus’’[Mesh])) OR (familial [tiab] AND ‘‘Epilepsy’’
[Mesh] AND ‘‘Myoclonus’’[Mesh])) OR (familial [tiab] AND ‘‘Tremor’’
[Mesh] AND ‘‘Myoclonus’’[Mesh])) OR (benign course [tiab] AND
‘‘Epilepsy’’[Mesh] OR benign course [tiab] AND epilepsy [tiab]))
OR (’’Tremor’’[Mesh] AND ‘‘Myoclonus’’[Mesh] OR tremor [tiab]
AND myoclonus [tiab] OR epilepsy [tiab] AND myoclonus [tiab]))))
OR (Autosomal dominant cortical myoclonus and epilepsy OR Benign
adult familial myoclonic epilepsy OR Cortical tremor OR Familial
adult myoclonic epilepsy OR Familial cortical myoclonic tremor OR
Familial cortical myoclonic tremor with epilepsy OR Familial cortical
tremor with epilepsy OR Familial essential myoclonus and epilepsy
OR Familial benign myoclonus epilepsy of adult onset OR Heredo-
familial tremor and epilepsy).
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